Australia's Control Bionics rises on US distribution deal
29/01/2026 04:47
** Shares of Australia's Control Bionics CBL.AX rise as much as 8.8% to A$0.062, their biggest intraday jump since January 15 ** Medical device co Control Bionics signs a deal with PRC-Saltillo (PRC), under which PRC will distribute co's NeuroNode tech in the US market ** NeuroNode is co's product for individuals with complex communication needs ** Last up 3.5% ** Shares down 3.3% in January (Reporting by Shruti Agarwal in Bengaluru) ((Shruti.Agarwal@thomsonreuters.com))
Recent news on Control Bionics
See all newsBrief: Control Bionics Posts Full-Year Loss Attributable Of A$7.3 Million
Brief: Control Bionics Sees FY27 Revenue Growth Of 50% Over FY26
Brief: Control Bionics Says Medicare Billing Code Secured For Nextlevel Speech Devices
Brief: Control Bionics Receives UK MHRA Registration For Neurostrip
Australia's Control Bionics jumps after FDA listing for NeuroStrip device